TY - JOUR
T1 - Novel CLCN1 mutations and clinical features of Korean patients with myotonia congenita
AU - Moon, In Soo
AU - Kim, Hyang Sook
AU - Shin, Jin Hong
AU - Park, Yeong Eun
AU - Park, Kyu Hyun
AU - Shin, Yong Bum
AU - Bae, Jong Seok
AU - Choi, Young Chul
AU - Kim, Dae Seong
PY - 2009/12
Y1 - 2009/12
N2 - Myotonia congenita (MC) is a form of nondystrophic myotonia caused by a mutation of CLCN1, which encodes human skeletal muscle chloride channel (CLC-1). We performed sequence analysis of all coding regions of CLCN1 in patients clinically diagnosed with MC, and identified 10 unrelated Korean patients harboring mutations. Detailed clinical analysis was performed in these patients to identify their clinical characteristics in relation to their genotypes. The CLCN1 mutational analyses revealed nine different point mutations. Of these, six (p.M128I, p.S189C, p.M373L, p.P480S, p.G523D, and p.M609K) were novel and could be unique among Koreans. While some features including predominant lower extremity involvement and normal to slightly elevated creatine kinase levels were consistently observed, general clinical features were highly variable in terms of age of onset, clinical severity, aggravating factors, and response to treatment. Our study is the first systematic study of MC in Korea, and shows its expanding clinical and genetic spectrums.
AB - Myotonia congenita (MC) is a form of nondystrophic myotonia caused by a mutation of CLCN1, which encodes human skeletal muscle chloride channel (CLC-1). We performed sequence analysis of all coding regions of CLCN1 in patients clinically diagnosed with MC, and identified 10 unrelated Korean patients harboring mutations. Detailed clinical analysis was performed in these patients to identify their clinical characteristics in relation to their genotypes. The CLCN1 mutational analyses revealed nine different point mutations. Of these, six (p.M128I, p.S189C, p.M373L, p.P480S, p.G523D, and p.M609K) were novel and could be unique among Koreans. While some features including predominant lower extremity involvement and normal to slightly elevated creatine kinase levels were consistently observed, general clinical features were highly variable in terms of age of onset, clinical severity, aggravating factors, and response to treatment. Our study is the first systematic study of MC in Korea, and shows its expanding clinical and genetic spectrums.
UR - http://www.scopus.com/inward/record.url?scp=75349109298&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=75349109298&partnerID=8YFLogxK
U2 - 10.3346/jkms.2009.24.6.1038
DO - 10.3346/jkms.2009.24.6.1038
M3 - Article
C2 - 19949657
AN - SCOPUS:75349109298
SN - 1011-8934
VL - 24
SP - 1038
EP - 1044
JO - Journal of Korean medical science
JF - Journal of Korean medical science
IS - 6
ER -